EP 1146050 A9 20011205 - REMEDIES
Title (en)
REMEDIES
Title (de)
MEDIKAMENTE
Title (fr)
MEDICAMENTS
Publication
Application
Priority
- JP 0000185 W 20000118
- JP 1164199 A 19990120
- JP 26711199 A 19990921
Abstract (en)
[origin: EP1146050A1] <CHEM> Compounds represented by general formula (I) wherein X represents OH or OSO3H; and R represents a substituent other than OH which allows, after leaving, the induction of unsaturated bonds into the 3- and 4-positions of 3,6-anhydrogalactose or its sulfated derivative, and/or a substituent showing a tissue-specific affinity.
IPC 1-7
C07H 3/10; C07H 11/00; C07H 13/06; C07H 13/08; C07H 15/18; A61K 31/7016; A61K 31/702; A61K 31/7024; A61K 31/7028; A23L 1/30; A61P 3/10; A61P 43/00; A61P 35/00
IPC 8 full level
A61P 3/10 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07H 3/10 (2006.01); C07H 11/00 (2006.01)
CPC (source: EP KR US)
A61P 3/10 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 31/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 493/08 (2013.01 - KR); C07H 3/10 (2013.01 - EP US); C07H 11/00 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
EP 1146050 A1 20011017; EP 1146050 A4 20020724; EP 1146050 A9 20011205; EP 1146050 B1 20091209; AT E451382 T1 20091215; AU 2005400 A 20000807; CN 1210285 C 20050713; CN 1344271 A 20020410; DE 60043497 D1 20100121; JP 4145494 B2 20080903; KR 100593393 B1 20060628; KR 20010089810 A 20011008; TW I290144 B 20071121; US 6518302 B1 20030211; WO 0043407 A1 20000727
DOCDB simple family (application)
EP 00900420 A 20000118; AT 00900420 T 20000118; AU 2005400 A 20000118; CN 00805208 A 20000118; DE 60043497 T 20000118; JP 0000185 W 20000118; JP 2000594823 A 20000118; KR 20017008728 A 20010710; TW 89100724 A 20000118; US 88972801 A 20010720